Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor

Journal: Nature Communications

Published: 2019-12-20

DOI: 10.1038/s41467-019-13646-9

Affiliations: 11

Authors: 24

Go to article
Institutions Share
Department of Computational Biology, St. Jude, United States of America (USA) 0.21
Department of Biostatistics, St. Jude, United States of America (USA) 0.19
Department of Surgery, St. Jude, United States of America (USA) 0.17
Department of Pathology, St. Jude, United States of America (USA) 0.17
Department of Surgery, UTHSC, United States of America (USA) 0.04
Hartwell Center for Bioinformatics and Biotechnology, St. Jude, United States of America (USA) 0.04
Department of Pediatric Oncology, DFCI, United States of America (USA) 0.04
Boston Children's Hospital (BCH), United States of America (USA) 0.04
Department of Oncology, Children's National Health System, United States of America (USA) 0.04
Greehey Children's Cancer Research Institute, UT Health San Antonio, United States of America (USA) 0.04
College of Nursing, UTHSC, United States of America (USA) 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER